Navigation Links
ProteinSimple Automates Aggregation Analysis
Date:10/25/2011

SANTA CLARA, Calif., Oct. 25, 2011 /PRNewswire/ -- ProteinSimple today announced the launch of the Bot1 High Throughput Autosampler for its MFI 5000 Micro-Flow Imaging platforms. Bot1 automates analysis of protein aggregates and particles by Micro-Flow imaging. Bot1 will be unveiled at the IBC's 11th Annual Formulation Strategy for Protein Therapeutics conference, November 1-3, 2011, in Long Beach, CA.

Protein therapeutic manufacturers must monitor microscopic particles and protein aggregates due to concerns about safety and immunogenicity. ProteinSimple's MFI systems measure visible and sub-visible particles and protein aggregates with unmatched accuracy and reproducibility, and have been adopted by major pharmaceutical and biotechnology companies worldwide.

This new integrated MFI system represents the world's first automated platform designed specifically for particle and protein aggregate monitoring. Automated analysis improves data quality, reduces labor costs and increases sample throughput, ultimately accelerating the development of protein therapeutics formulations.

"Manual sample introduction for traditional particle counters is painfully tedious," commented Susan Darling, Director of Product Management.  "MFI systems have been embraced by our customers for their ability to accurately characterize and quantify sub-visible particles.  Bot1's automation further distinguishes MFI from our competitors.  Formulation development scientists will realize new levels of speed, reproducibility and accuracy."

About ProteinSimple

ProteinSimple's goal is simply to help researchers gain a better understanding of proteins and their role in disease. The Company's strategy is to power protein research by making it simpler and more quantitative, ultimately revealing new insights into the true nature of proteins. ProteinSimple has built a unique portfolio of protein analysis tools including systems for traditional protein imaging, systems to probe the structure and purity of protein based therapeutics and systems that provide fresh insight into protein signaling. ProteinSimple has over 180 employees, more than 10,000 systems installed around the world and is headquartered in Santa Clara, California. For more information, visit www.proteinsimple.com.


'/>"/>
SOURCE ProteinSimple
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. ProteinSimple Launches New System for Protein Biologics
2. ProteinSimple Reinvents the Western Blot
3. Cell Biosciences Changes Name to ProteinSimple
4. LI-COR Blot Washer Automates Western Blot Processing
5. Ventana Receives FDA Clearance for HER2 (4B5) Image Analysis and Digital Read Applications
6. Metabolomx Awarded $1.14 Million SBIR Grant from National Cancer Institute for Breath Analysis Test of Lung Cancer
7. Caliper Life Sciences Collaborates With Yale Center for Genome Analysis to Automate Next Generation Sequencing Workflows
8. Strategic Analysis of Indian Biosimilar Market
9. Global Genetic Testing Market Analysis
10. Effient® (Prasugrel) Showed Significant 26 Percent Reduction in Cardiovascular Events Over Clopidogrel in New Core Clinical Cohort Population Sub-Analysis of the TRITON-TIMI 38 Pivotal Study
11. Elsevier Integrates New Collaboration Analysis Capabilities Into SciVal Strata to Further Enhance Research Evaluation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Houston Methodist Willowbrook Hospital has signed ... to serve as their official health care provider. ... will provide sponsorship support, athletic training services, and ... volunteers, athletes and families. "We are ... and to bring Houston Methodist quality services and ...
(Date:6/23/2016)... FRANCISCO , June 23, 2016   EpiBiome ... has secured $1 million in debt financing from Silicon ... ramp up automation and to advance its drug development ... its new facility. "SVB has been an ... beyond the services a traditional bank would provide," said ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, ... Pennsylvania Convention Center and will showcase its product’s latest features from June 26 ... presenting a scientific poster on Disrupting Clinical Trials in The Cloud during the ...
Breaking Biology Technology:
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 ... of Infosys (NYSE: INFY ), and Samsung SDS, ... partnership that will provide end customers with a more ... payment services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) ... financial services, but it also plays a fundamental part in ...
(Date:4/15/2016)... 2016  A new partnership announced today will ... decisions in a fraction of the time it ... high-value life insurance policies to consumers without requiring ... Force Diagnostics, rapid testing (A1C, Cotinine and HIV) ... pressure, weight, pulse, BMI, and activity data) available ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys ... founding CEO, Barrett Bready , M.D., who returned ... of the original technical leadership team, including Chief Technology ... of Product Development, Steve Nurnberg and Vice President of ... to the company. Dr. Bready served as ...
Breaking Biology News(10 mins):